Old National Bancorp’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.1M | Buy |
273,640
+32,362
| +13% | +$1.39M | 0.26% | 72 |
|
|
2026
Q1 | $8.87M | Buy |
241,278
+190,493
| +375% | +$9.03M | 0.15% | 124 |
|
|
2025
Q4 | $2.58M | Buy |
50,785
+38,631
| +318% | +$1.98M | 0.04% | 227 |
|
|
2025
Q3 | $674K | Buy |
12,154
+5,251
| +76% | +$307K | 0.01% | 349 |
|
|
2025
Q2 | $476K | Buy |
6,903
+3,140
| +83% | +$214K | 0.01% | 380 |
|
|
2025
Q1 | $261K | Sell |
3,763
-236
| -6% | -$19.5K | 0.01% | 436 |
|
|
2024
Q4 | $344K | Sell |
3,999
-400
| -9% | -$43.3K | 0.01% | 475 |
|
|
2024
Q3 | $524K | Buy |
4,399
+1,027
| +30% | +$137K | 0.01% | 382 |
|
|
2024
Q2 | $481K | Sell |
3,372
-276
| -8% | -$36.6K | 0.01% | 374 |
|
|
2024
Q1 | $468K | Buy |
+3,648
| New | +$434K | 0.01% | 384 |
|
|
2020
Q1 | – | Sell |
-8,354
| Closed | -$242K | – | 540 |
|
|
2019
Q4 | $242K | Buy |
8,354
+66
| +0.8% | +$1.83K | 0.01% | 485 |
|
|
2019
Q3 | $215K | Sell |
8,288
-10
| -0.1% | -$253 | 0.01% | 511 |
|
|
2019
Q2 | $212K | Sell |
8,298
-546
| -6% | -$13.5K | 0.01% | 530 |
|
|
2019
Q1 | $231K | Sell |
8,844
-272
| -3% | -$6.68K | 0.01% | 503 |
|
|
2018
Q4 | $210K | Buy |
+9,116
| New | +$203K | 0.01% | 519 |
|
|
2016
Q4 | – | Sell |
-19,514
| Closed | -$406K | – | 635 |
|
|
2016
Q3 | $406K | Sell |
19,514
-5,198
| -21% | -$129K | 0.02% | 407 |
|
|
2016
Q2 | $665K | Sell |
24,712
-3,354
| -12% | -$92K | 0.04% | 284 |
|
|
2016
Q1 | $761K | Sell |
28,066
-1,012
| -3% | -$27.1K | 0.04% | 268 |
|
|
2015
Q4 | $845K | Sell |
29,078
-646
| -2% | -$17.9K | 0.05% | 247 |
|
|
2015
Q3 | $806K | Sell |
29,724
-320
| -1% | -$9.06K | 0.05% | 240 |
|
|
2015
Q2 | $823K | Sell |
30,044
-7,836
| -21% | -$220K | 0.05% | 250 |
|
|
2015
Q1 | $1.01M | Buy |
37,880
+3,054
| +9% | +$70.3K | 0.06% | 224 |
|
|
2014
Q4 | $737K | Buy |
34,826
+3,780
| +12% | +$84.4K | 0.05% | 239 |
|
|
2014
Q3 | $739K | Buy |
31,046
+3,420
| +12% | +$78.7K | 0.05% | 240 |
|
|
2014
Q2 | $638K | Sell |
27,626
-9,696
| -26% | -$214K | 0.05% | 231 |
|
|
2014
Q1 | $852K | Sell |
37,322
-3,388
| -8% | -$72.2K | 0.08% | 145 |
|
|
2013
Q4 | $752K | Sell |
40,710
-2,300
| -5% | -$40.1K | 0.07% | 120 |
|
|
2013
Q3 | $728K | Buy |
43,010
+1,780
| +4% | +$29.9K | 0.07% | 105 |
|
|
2013
Q2 | $639K | Buy |
+41,230
| New | +$686K | 0.07% | 111 |
|
Other funds holding NVO
F
Old National Bancorp's NVO Position: Q2 2026 in Review
Old National Bancorp increased its Novo Nordisk (NVO) stake by 13% in Q2 2026, buying an estimated $1.39M and bringing the position to 273,640 shares worth $13.1M. The position accounts for 0.26% of the portfolio, ranked #72.
Old National Bancorp first reported a position in NVO in Q2 2013 and has held it in 29 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Old National Bancorp held 273,640 shares of Novo Nordisk worth $13.1M as of Q2 2026.
- Old National Bancorp bought 32,362 Novo Nordisk shares in Q2 2026, an estimated $1.39M.
- Novo Nordisk made up 0.26% of Old National Bancorp's portfolio in Q2 2026, its #72 holding.
- Old National Bancorp first reported a position in Novo Nordisk in Q2 2013 and has held it in 29 quarters since.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.